Multimodal Computed Tomography in Patients With Acute Hemorrhagic Stroke

NCT06061185 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2025-04-04

No results posted yet for this study

Summary

Acute hemorrhagic stroke is a series of neurosurgical diseases characterized by bleeding with high morbidity and mortality. It accounts for about 20% of all strokes worldwide and mainly includes subtypes such as intracerebral hemorrhage (ICH) and subarachnoid hemorrhage (SAH). Multimodal computed tomography including non-contrast computed tomography, computed tomography angiography and computed tomography perfusion, is of great important in understanding pathophysiological changes, evaluating prognosis and guiding interventions in these diseases.

Conditions

  • Acute Hemorrhagic Stroke

Interventions

DEVICE

Multimodal CT

Non-contrast computed tomography, computed tomography angiography and computed tomography perfusion

Sponsors & Collaborators

  • Peking University International Hospital

    collaborator OTHER
  • Zhangzhou Municipal Hospital of Fujian Province

    collaborator OTHER
  • The First Affiliated Hospital of Shanxi Medical University

    collaborator OTHER
  • Santai County People's Hospital

    collaborator UNKNOWN
  • Jiujiang No.1 People's Hospital

    collaborator UNKNOWN
  • Qin Zhou NO.1 People's Hospital

    collaborator UNKNOWN
  • Sichuan Academy of Medical Sciences

    collaborator OTHER
  • Linyi People's Hospital

    collaborator OTHER
  • Xiaolin Chen, MD

    lead OTHER

Principal Investigators

  • Tu Li, M.D. · Beijing Tiantan Hospital

  • Zhenshan Song, M.D. · Beijing Tiantan Hospital

  • Runting Li, M.D. · Beijing Tiantan Hospital

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2032-03-01
Completion
2032-04-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06061185 on ClinicalTrials.gov